Finance Next Wave

InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with recurring revenue from its BayMedica manufacturing…

Editor's pick

Business

Editor's pick

Investing

InMed Pharmaceuticals: Innovating Cannabinoid-inspired Medicines, Backed by Real Revenue and Clear Path to Value

Stock

Latest

Snow Lake Completes Due Diligence and Confirms Placement

Crypto Market Update: Trump Orders 401(k) Crypto Review, ETH Treasury Vehicle Files to Raise Billions

Tech 5: Tesla Pulls Plug on Dojo, Chipmakers Largely Exempt from Trump’s Tariffs

Lode Gold Completes Final Tranche Financing for Total $1.51 Million

Agriculture Market Update: Q2 2025 in Review

Prismo Metals Announces Closing of Oversubscribed Private Placement

CHARBONE presentera a la conference Hydrogen East et annonce le developpement d’un hub d’approvisionnement dans le marche de l’Atlantique via sa filiale

Tartisan Nickel Corp. Intersects 24.6 Metres of 0.71% Ni, 0.56% Cu Including 6.1 Metres of 1.17% Ni, 1.45% Cu at the Kenbridge Nickel-Copper-Cobalt Project, Northwestern Ontario

LaFleur Minerals Inc.Taking Key Steps to Advance Position in Prolific Gold Belt